ASSET | MONTH | % RETURN |
---|---|---|
Biohaven Pharmaceutical (BHVN) | October 2022 | 159.31% |
Advantage Solutions (ADVWW) | October 2022 | 129.77% |
Immunovant (IMVT) | October 2022 | 97.53% |
Spyre Therapeutics (SYRE) | October 2022 | 94.34% |
Enliven Therapeutics (ELVN) | October 2022 | 92.21% |
SS Innovations International Inc Common Stock (SSII) | October 2022 | 84.09% |
Nuvalent (NUVL) | October 2022 | 82.57% |
Vaxcyte (PCVX) | October 2022 | 78% |
ADEIA (ADEA) | October 2022 | 68.12% |
Oceaneering International (OII) | October 2022 | 66.15% |
89bio (ETNB) | October 2022 | 63.25% |
Roivant Sciences (ROIV) | October 2022 | 61.64% |
Avis Budget (CAR) | October 2022 | 54.34% |
QXO (QXO) | October 2022 | 50.69% |
Tidewater (TDW) | October 2022 | 50.67% |
Viking Therapeutics (VKTX) | October 2022 | 48.55% |
Calumet Specialty Products Partners (CLMT) | October 2022 | 48.47% |
DexCom (DXCM) | October 2022 | 48.25% |
Norwegian Cruise Line (NCLH) | October 2022 | 46.23% |
Tilray (TLRY) | October 2022 | 45.88% |
Vertiv (VRT) | October 2022 | 44.11% |
Impinj (PI) | October 2022 | 42.95% |
Greenbrier Companies (GBX) | October 2022 | 42.84% |
Seadrill (SDRL) | October 2022 | 42.53% |
Patterson-UTI Energy (PTEN) | October 2022 | 42.13% |